GenMark Diagnostics Inc (GNMK) - Product Pipeline Analysis, 2018 Update

GenMark Diagnostics Inc (GNMK) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME238011PD
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test, and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis, among others. The company provides educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity, among others. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company GenMark Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

GenMark Diagnostics Inc Company Overview 5

GenMark Diagnostics Inc Company Snapshot 5

GenMark Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenMark Diagnostics Inc - Pipeline Analysis Overview 8

GenMark Diagnostics Inc - Key Facts 8

GenMark Diagnostics Inc - Major Products and Services 9

GenMark Diagnostics Inc Pipeline Products by Development Stage 10

GenMark Diagnostics Inc Pipeline Products Overview 12

2D6 Tamoxifen Metabolism Test 12

2D6 Tamoxifen Metabolism Test Product Overview 12

ePlex Blood Culture Identification Fungal Pathogen Panel 13

ePlex Blood Culture Identification Fungal Pathogen Panel Product Overview 13

ePlex Blood Culture Identification Gram-Negative Panel 14

ePlex Blood Culture Identification Gram-Negative Panel Product Overview 14

ePlex Blood Culture Identification Gram-Positive Panel 15

ePlex Blood Culture Identification Gram-Positive Panel Product Overview 15

ePlex Central Nervous System Panel 16

ePlex Central Nervous System Panel Product Overview 16

ePlex Gastrointestinal Pathogen Panel 17

ePlex Gastrointestinal Pathogen Panel Product Overview 17

ePlex HCV Genotyping Panel 18

ePlex HCV Genotyping Panel Product Overview 18

eSensor 2C19 Genotyping Test 19

eSensor 2C19 Genotyping Test Product Overview 19

eSensor 3A4/3A5 Genotyping Test 20

eSensor 3A4/3A5 Genotyping Test Product Overview 20

eSensor KRAS Test 21

eSensor KRAS Test Product Overview 21

Fully Integrated In-Vitro Diagnostic Platform 22

Fully Integrated In-Vitro Diagnostic Platform Product Overview 22

GenMark Diagnostics Inc - Key Competitors 23

GenMark Diagnostics Inc - Key Employees 24

GenMark Diagnostics Inc - Locations And Subsidiaries 25

Head Office 25

Recent Developments 26

GenMark Diagnostics Inc, Recent Developments 26

Jun 28, 2018: GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel 26

May 01, 2018: GenMark Diagnostics Announces First Quarter 2018 Financial Results 26

Feb 27, 2018: GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results 26

Nov 02, 2017: GenMark Diagnostics Reports Third Quarter 2017 Results 27

Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 28

Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive and Gram-Negative Panels 28

Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive Panel 29

Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Negative Panel 29

Jun 12, 2017: GenMark Receives FDA 510(k) Market Clearance for ePlex Instrument 29

Jun 12, 2017: GenMark Receives FDA 510(k) Market Clearance For Its ePlex Respiratory Pathogen Panel 30

Appendix 32

Methodology 32

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

GenMark Diagnostics Inc Pipeline Products by Equipment Type 6

GenMark Diagnostics Inc Pipeline Products by Development Stage 10

List of Tables

GenMark Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

GenMark Diagnostics Inc Pipeline Products by Equipment Type 6

GenMark Diagnostics Inc Pipeline Products by Indication 7

GenMark Diagnostics Inc, Key Facts 8

GenMark Diagnostics Inc, Major Products and Services 9

GenMark Diagnostics Inc Number of Pipeline Products by Development Stage 10

GenMark Diagnostics Inc Pipeline Products Summary by Development Stage 11

2D6 Tamoxifen Metabolism Test - Product Status 12

2D6 Tamoxifen Metabolism Test - Product Description 12

ePlex Blood Culture Identification Fungal Pathogen Panel - Product Status 13

ePlex Blood Culture Identification Fungal Pathogen Panel - Product Description 13

ePlex Blood Culture Identification Gram-Negative Panel - Product Status 14

ePlex Blood Culture Identification Gram-Negative Panel - Product Description 14

ePlex Blood Culture Identification Gram-Positive Panel - Product Status 15

ePlex Blood Culture Identification Gram-Positive Panel - Product Description 15

ePlex Central Nervous System Panel - Product Status 16

ePlex Central Nervous System Panel - Product Description 16

ePlex Gastrointestinal Pathogen Panel - Product Status 17

ePlex Gastrointestinal Pathogen Panel - Product Description 17

ePlex HCV Genotyping Panel - Product Status 18

ePlex HCV Genotyping Panel - Product Description 18

eSensor 2C19 Genotyping Test - Product Status 19

eSensor 2C19 Genotyping Test - Product Description 19

eSensor 3A4/3A5 Genotyping Test - Product Status 20

eSensor 3A4/3A5 Genotyping Test - Product Description 20

eSensor KRAS Test - Product Status 21

eSensor KRAS Test - Product Description 21

Fully Integrated In-Vitro Diagnostic Platform - Product Status 22

Fully Integrated In-Vitro Diagnostic Platform - Product Description 22

GenMark Diagnostics Inc, Key Employees 24

Glossary 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Epinex Diagnostics Inc

Cepheid

Nanosphere Inc

Illumina Inc

Luminex Corp

GenMark Diagnostics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53925
Site License
USD 1500 INR 107850
Corporate User License
USD 2250 INR 161775

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com